Amare Global Holdings Inc.
The FTC alleged that Amare Global Holdings made unsupported health claims for dietary supplements and misleading earnings claims to seller recruits, and asked a federal court to hold the company and three individuals in contempt.
Documented. Subject of a regulatory action, lawsuit, or other official proceeding on the public record.
Identity
Published so you can confirm this entry refers to the party you are checking, and not to somebody who shares a name.
- Registrations
- FTC v. Amare Global Holdings Inc. (FTC federal injunction, 2026)
- Jurisdictions
- United States (federal)
FTC alleges unsupported health and earnings claims
The FTC sued multilevel marketer Amare Global Holdings Inc. and three of its principals. According to the supplied case description, the agency alleged that the company misrepresented to parents and other consumers that dietary supplements marketed for children and adults could treat or cure depression, anxiety, and ADHD. The FTC also alleged that Amare misled recruits about the earnings they could make as brand partners.
The description also says the FTC asked a federal court to hold Amare, former Chief Science Officer Shawn Talbott, and two other individuals in contempt. The contempt allegations concern an FTC order in the Window Rock case that banned Talbott and people who work with him from making false, deceptive, or unsubstantiated health claims. The supplied description does not state the result of the lawsuit or the contempt request.
Sources
Every claim above rests on one of these. Open them and check.
- Enforcement action June 12, 2026
Right of reply
If you are named here and something is wrong, dispute this entry. There is no charge, the route never expires, and your response is published unedited.
Other coaching & business opportunity entries
See all coaching & business opportunity entries, or browse the full record.
First recorded June 12, 2026 · Last updated June 12, 2026